These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes. Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774 [TBL] [Abstract][Full Text] [Related]
23. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP; Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789 [TBL] [Abstract][Full Text] [Related]
24. Analysis of mRNA in renal allografts using polymerase chain reaction amplification. Williamson P; Allen RD; Chapman JR; Stewart GJ Transplant Proc; 1992 Feb; 24(1):205-7. PubMed ID: 1539249 [No Abstract] [Full Text] [Related]
26. New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations. Brunet M; Millán O; Jiménez O; Campistol JM; Vidal E; Rojo I; Oppenheimer F; Fortuna V; Martorell J Transplant Proc; 2004 Mar; 36(2 Suppl):437S-441S. PubMed ID: 15041382 [TBL] [Abstract][Full Text] [Related]
27. The role of interleukin-6 in mitogenic T-cell activation: detection of interleukin-2 heteronuclear RNA by polymerase chain reaction. Walz G; Stevens C; Zanker B; Melton LB; Clark SC; Suthanthiran M; Strom TB Cell Immunol; 1991 May; 134(2):511-9. PubMed ID: 1827050 [TBL] [Abstract][Full Text] [Related]
28. Molecular and structural consequences of early renal allograft injury. Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412 [TBL] [Abstract][Full Text] [Related]
29. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111 [TBL] [Abstract][Full Text] [Related]
30. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019 [TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older. Sommerer C; Schnitzler P; Meuer S; Zeier M; Giese T Ther Drug Monit; 2011 Dec; 33(6):694-8. PubMed ID: 22105585 [TBL] [Abstract][Full Text] [Related]
32. Physiologic signaling in normal human T-cells: mRNA phenotyping by northern blot analysis and reverse transcription-polymerase chain reaction. Wieder KJ; Walz G; Zanker B; Sehajpal P; Sharma VK; Skolnik E; Strom TB; Suthanthiran M Cell Immunol; 1990 Jun; 128(1):41-51. PubMed ID: 1971531 [TBL] [Abstract][Full Text] [Related]
33. Effects of immunosuppression by cyclosporine A on allogenic uterine transplant in the rat. Groth K; Akhi SN; Mölne J; Wranning CA; Brännström M Eur J Obstet Gynecol Reprod Biol; 2012 Jul; 163(1):97-103. PubMed ID: 22502817 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Iacono A; Dauber J; Keenan R; Spichty K; Cai J; Grgurich W; Burckart G; Smaldone G; Pham S; Ohori NP; Yousem S; Williams P; Griffith B; Zeevi A Transplantation; 1997 Jul; 64(2):263-9. PubMed ID: 9256185 [TBL] [Abstract][Full Text] [Related]
36. [Expressions of interleukin-15 and osteopontin mRNA in early stage of acute rejection of renal allograft in rats]. Ouyang J; He J; Fan YS; Fan CB; Sun HY; Wen DG Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):698-702. PubMed ID: 20450731 [TBL] [Abstract][Full Text] [Related]
37. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression. Sommerer C; Giese T; Schmidt J; Meuer S; Zeier M Transplantation; 2008 Jan; 85(1):15-21. PubMed ID: 18192906 [TBL] [Abstract][Full Text] [Related]
38. A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function. Hong JC; Kahan BD Transplantation; 2001 May; 71(9):1320-8. PubMed ID: 11397971 [TBL] [Abstract][Full Text] [Related]
39. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. Shoker A; George D; Yang H; Baltzan M Transplantation; 2000 Aug; 70(3):497-505. PubMed ID: 10949194 [TBL] [Abstract][Full Text] [Related]
40. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription. Rolfe FG; Valentine JE; Sewell WA Am J Respir Cell Mol Biol; 1997 Aug; 17(2):243-50. PubMed ID: 9271313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]